Want to track IMMNOV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immunovia AB (publ) (IMMNOV) Statistics
Valuation metrics
Market Cap 102.68M
Enterprise value -4.57M
Trailing P/E (ttm) -0.47
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 22.36
Price/Book (mrq) 2.25
Enterprise Value/Revenue -3.78
Enterprise Value/EBITDA 0.06
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 9.71M
Average volume (90 days) 4.11M
Price summary
52-Week low 0.15
52-Week high 0.75
Beta -
50-Day moving average 0.13
200-Day moving average 0.17
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:100
Last split Date 3 Feb 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -73%
Operating margin -68.3%
Operational effectiveness
Return on assets -1.84%
Return on equity -2.79%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.05
Total debt (mrq) -
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 1.57%
Book value per share (mrq) 0.04
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
